Scil Proteins Signs Licensing And Pre Manufacturing Agreement With Anabasis/Dompé For Eye Indications
Scil Proteins, a private biopharmaceutical company specialized in the research, development and production of recombinant proteins, today announced that it has signed an agreement with Anabasis Pharma.